InvestorsHub Logo
Followers 3
Posts 104
Boards Moderated 0
Alias Born 07/15/2016

Re: Lakersrback post# 13602

Tuesday, 10/16/2018 10:33:46 AM

Tuesday, October 16, 2018 10:33:46 AM

Post# of 27409
Lakers, you are not a bad guy but you are focusing on the wrong things. Accept the fact that Cytosorb is efficacious. It is in use daily in dozens of countries. It has been proved to work in numerous indications. There is a single hospital in German buying $1 million in product annually. Because it works. On the other hand, the FDA is stodgy, clueless, numb and dopey when it comes to something other than giving a patient a pill or a shot. The FDA is "additive" meaning they keep thinking that the only way to solve a medical issue is to put something else in the patient. Cytosorb is substractive. It takes bad actors out of the body. The FDA doesn't easily get this concept, except for dialysis. Go figure. If you keep focusing on the FDA, you miss the opportunity with CTSO. This company is growing without the FDA. If you are dead set on the FDA approving Cytosorb, come back in a year or two. Meanwhile, this company simply continues to grow sales, revenues, expand to new countries, increase its global patient population base, save lives for a host of important illnesses, etc. IMHO, focus on international sales and buy on the dips.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News